• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于癌症干细胞抗原特性的癌症免疫治疗新方法。

A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties.

机构信息

Department of Medical Biotechnology, Fasa University of Medical Sciences, Fasa, Iran.

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Curr Mol Med. 2019;19(1):2-11. doi: 10.2174/1566524019666190204114721.

DOI:10.2174/1566524019666190204114721
PMID:30714514
Abstract

BACKGROUND

Cancer stem cells (CSCs) are a rare population of tumor cells, which play an important role in tumor initiation, progression, and maintenance. The concept that cancer cells arise from stem cells was presented about 150 years ago. Recently, this hypothesis was renewed considering the heterogeneity of tumor cells. CSCs are resistant to chemo- and radio-therapy. Therefore, targeting CSCs could be a novel and effective strategy to struggle with tumor cells.

OBJECTIVE

In this mini-review, we highlight that different immunotherapeutic approaches can be used to target cancer cells and eradicate different tumor cells. The most important targets are specific markers recognized on the CSC surface as CSC antigens such as CD44, CD133, Aldehyde Dehydrogenase (ALDH), and SOX family members. This article emphasizes recent advances in CSCs in cancer therapy.

RESULTS

Our results present that CSC antigens play an important role in tumor initiation, especially in the cells that are resistant to chemo- and radiotherapy agents. Therefore, they are ideal targets for cancer immunotherapy, for instance, in developing different types of cancer vaccines or antibodies against tumor cells.

CONCLUSION

The current studies related to cancer immunotherapy through targeting the CSC antigens based on their properties are briefly summarized. Altogether, CSC antigens can be efficiently targeted to treat cancer patients.

摘要

背景

癌症干细胞(CSCs)是肿瘤细胞中的一个稀有群体,在肿瘤的起始、进展和维持中起着重要作用。大约 150 年前就提出了癌细胞起源于干细胞的概念。最近,考虑到肿瘤细胞的异质性,这一假说得到了更新。CSCs 对化疗和放疗有抵抗力。因此,针对 CSCs 可能是与肿瘤细胞作斗争的一种新的有效策略。

目的

在这篇迷你综述中,我们强调了不同的免疫治疗方法可用于靶向癌细胞并消灭不同的肿瘤细胞。最重要的靶标是 CSC 表面上识别的特定标志物,如 CD44、CD133、醛脱氢酶(ALDH)和 SOX 家族成员等 CSC 抗原。本文强调了 CSCs 在癌症治疗中的最新进展。

结果

我们的结果表明,CSC 抗原在肿瘤起始中起着重要作用,特别是在对化疗和放疗药物有抵抗力的细胞中。因此,它们是癌症免疫治疗的理想靶点,例如,开发针对肿瘤细胞的不同类型癌症疫苗或抗体。

结论

简要总结了基于 CSC 抗原特性通过靶向 CSC 抗原进行癌症免疫治疗的当前研究。总之,CSC 抗原可作为治疗癌症患者的有效靶点。

相似文献

1
A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties.基于癌症干细胞抗原特性的癌症免疫治疗新方法。
Curr Mol Med. 2019;19(1):2-11. doi: 10.2174/1566524019666190204114721.
2
[Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy].[癌症干细胞抗原的鉴定与细胞毒性T淋巴细胞介导的癌症免疫疗法的发展]
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(1):40-47. doi: 10.2177/jsci.40.40.
3
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.癌症干细胞免疫学和免疫疗法:利用免疫系统对抗癌症的根源。
Prog Mol Biol Transl Sci. 2019;164:119-188. doi: 10.1016/bs.pmbts.2019.03.008. Epub 2019 Apr 11.
4
A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model.利用载有化疗耐药性肿瘤干细胞样细胞的树突状细胞增强实验小鼠模型抗肿瘤免疫反应的新策略。
Mol Immunol. 2019 Jul;111:106-117. doi: 10.1016/j.molimm.2019.04.001. Epub 2019 Apr 30.
5
Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.简要综述:利用免疫方法靶向癌症干细胞
Stem Cells. 2015 Jul;33(7):2085-92. doi: 10.1002/stem.2039. Epub 2015 May 13.
6
Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.针对人源肿瘤干细胞/肿瘤起始细胞表达的肿瘤抗原的免疫应答。
Immunotherapy. 2010 Mar;2(2):201-11. doi: 10.2217/imt.10.10.
7
Immunologic Targeting of Cancer Stem Cells.癌症干细胞的免疫靶向治疗。
Surg Oncol Clin N Am. 2019 Jul;28(3):431-445. doi: 10.1016/j.soc.2019.02.010. Epub 2019 Apr 10.
8
Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.使用卵巢癌干细胞疫苗进行靶向卵巢癌免疫治疗的效果。
J Ovarian Res. 2015 Oct 24;8:68. doi: 10.1186/s13048-015-0196-5.
9
Cancer stem cell antigens as targets for new combined anti-cancer therapies.癌症干细胞抗原作为新的联合抗癌疗法的靶点。
Int J Biochem Cell Biol. 2020 Dec;129:105861. doi: 10.1016/j.biocel.2020.105861. Epub 2020 Oct 5.
10
Breast cancer stem cell antigens as targets for immunotherapy.乳腺癌干细胞抗原作为免疫治疗的靶点。
Semin Immunol. 2020 Feb;47:101386. doi: 10.1016/j.smim.2020.101386. Epub 2020 Jan 10.

引用本文的文献

1
Moxibustion of Zusanli (ST36) and Shenshu (BL23) alleviates the inflammation of rheumatoid arthritis in rats through regulating macrophage migration inhibitory factor/glucocorticoids signaling.足三里(ST36)和肾俞(BL23)艾灸通过调节巨噬细胞移动抑制因子/糖皮质激素信号减轻类风湿性关节炎大鼠的炎症。
J Tradit Chin Med. 2024 Apr;44(2):353-361. doi: 10.19852/j.cnki.jtcm.20220602.001.
2
Involving stemness factors to improve CAR T-cell-based cancer immunotherapy.将干性因子纳入 CAR T 细胞癌症免疫疗法中以提高疗效。
Med Oncol. 2023 Oct 1;40(11):313. doi: 10.1007/s12032-023-02191-7.
3
Aldehyde Dehydrogenase, Liver Disease and Cancer.
醛脱氢酶、肝脏疾病与癌症。
Int J Biol Sci. 2020 Jan 22;16(6):921-934. doi: 10.7150/ijbs.42300. eCollection 2020.